PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 19729048-4 2009 The application of urocortin reversibly inhibited both VOCC and the frequency of DA release events via the activation of type-1 CRF receptor. Urocortins 19-28 corticotropin releasing hormone receptor 1 Homo sapiens 121-140 22547117-5 2013 Application of CRF and urocortin (UCN) to cerebellar slice cultures increased the density of spines on PC signaling via CRF receptors (CRF-Rs) 1 and 2 and RhoA downregulation, although the structural phenotypes of the induced spines varied, suggesting that CRF-Rs differentially induce the outgrowth of functionally distinct populations of spines. Urocortins 23-32 corticotropin releasing hormone receptor 1 Homo sapiens 135-150 20821057-5 2010 The protective effect of urocortin involved the activation of CRF receptor type 1, resulting in the increase of cyclic AMP (cAMP) levels. Urocortins 25-34 corticotropin releasing hormone receptor 1 Homo sapiens 62-81 17976162-4 2008 CRF(1)-preferring or non-selective agonists such as CRF, urocortin 1 (UCN1), and sauvagine stimulated cAMP production in Y79 to maximal responses of approximately 100 pmoles/10(5) cells, whereas the exclusive CRF2 receptor-selective agonists UCN2 and 3 stimulated cAMP production to maximal responses of approximately 25-30 pmoles/10(5) cells. Urocortins 57-68 corticotropin releasing hormone receptor 1 Homo sapiens 0-5 17170072-10 2007 Despite the substantial intracellular degradation of endocytosed urocortin in cells overexpressing either CRHR1 or CRHR2, intact urocortin could be exocytosed during the 1-h study interval. Urocortins 65-74 corticotropin releasing hormone receptor 1 Homo sapiens 106-111 15206947-4 2004 Soluble isoforms could modulate cell response with CRFR1e attenuating and CRFR1h amplifying CRFR1alpha-coupled cAMP production stimulated by urocortin. Urocortins 141-150 corticotropin releasing hormone receptor 1 Homo sapiens 74-79 17952632-8 2007 Urocortin induced significant Stat3 but not Stat1 activation, mediated by either CRHR1 or CRHR2. Urocortins 0-9 corticotropin releasing hormone receptor 1 Homo sapiens 81-86 16959871-1 2006 In most target cells, activation of the type 1 CRH receptor (CRH-R1) by CRH or urocortin (UCN I) leads to stimulation of the Gs-protein/adenylyl cyclase/protein kinase A cascade. Urocortins 79-88 corticotropin releasing hormone receptor 1 Homo sapiens 61-67 9423932-6 1997 Thus, for the recombinant CRF1 receptor, binding was inhibited with similar affinity by Urocortin, sauvagine, Urotensin 1 and CRF. Urocortins 88-97 corticotropin releasing hormone receptor 1 Homo sapiens 26-30 14657255-1 2004 Activation of CRH receptors type 1 (CRH-R1) by CRH or urocortin (UCN) leads to stimulation of multiple G proteins with consequent effects on diverse signaling cascades in a tissue-specific manner. Urocortins 54-63 corticotropin releasing hormone receptor 1 Homo sapiens 14-34 14657255-1 2004 Activation of CRH receptors type 1 (CRH-R1) by CRH or urocortin (UCN) leads to stimulation of multiple G proteins with consequent effects on diverse signaling cascades in a tissue-specific manner. Urocortins 54-63 corticotropin releasing hormone receptor 1 Homo sapiens 36-42 11784785-7 2002 Using subtype-selective CRH receptor antagonists, we provide evidence that the neuroprotective effect of exogenously added urocortin is mediated by CRHR1. Urocortins 123-132 corticotropin releasing hormone receptor 1 Homo sapiens 148-153 11425856-6 2001 Following thrombin cleavage, the purified protein (bNT-CRFR1) binds astressin and the agonist urocortin with high affinity. Urocortins 94-103 corticotropin releasing hormone receptor 1 Homo sapiens 55-60 9423932-9 1997 The pharmacological profile of specific [3H]-urocortin binding to homogentates of rat cerebellum was consistent with specific labelling of a CRF1 receptor. Urocortins 45-54 corticotropin releasing hormone receptor 1 Homo sapiens 141-145 7477349-5 1995 Synthetic urocortin evokes secretion of adrenocorticotropic hormone (ACTH) both in vitro and in vivo and binds and activates transfected type-1 CRF receptors, the subtype expressed by pituitary corticotropes. Urocortins 10-19 corticotropin releasing hormone receptor 1 Homo sapiens 137-157